Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Imperial Valley College, Baylor University Medical Center, British Heart Foundation, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, University of Mississippi, National and Kapodistrian University of Athens, University of London, London School of Hygiene & Tropical Medicine, Washington DC VA Medical Center, Harvard University, Massachusetts General Hospital, St. Michael's Hospital, University of Toronto, Kyushu University, University of Mannheim, Heidelberg University, Boehringer Ingelheim (Taiwan), Boehringer Ingelheim (Canada), Boehringer Ingelheim (United States), Boehringer Ingelheim (Germany), Universidade de São Paulo, Saarland University, Seoul National University, Max Super Speciality Hospital, Instituto Nacional de Cardiología, McGill University Health Centre, Chinese Academy of Medical Sciences & Peking Union Medical College, Universidade de Santiago de Compostela, Cedars-Sinai Medical Center, Maastricht University Medical Centre, Semmelweis University, Monash University, Hospital El Cruce, Wroclaw Medical University, University of Glasgow, Ospedale Papa Giovanni XXIII, Centre Hospitalier Universitaire de Besançon, University Hospital Brno, University of Leicester, Glenfield Hospital, National Institute for Health Research, NIHR Biomedical Research Centre at The Royal Marsden and the ICR, University of Pisa, Universitätsklinikum Würzburg, French Clinical Research Infrastructure Network, Université de Lorraine